Clinical Trial Update: Comprehensive Nano - Post Market Clinical Follow-Up Study

View source ↗

Summary

A post-market clinical follow-up study by Zimmer Biomet under the Comprehensive Nano program to monitor outcomes in patients with osteoarthritis, avascular necr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis
• Rheumatoid Arthritis

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Avascular Necrosis | Status: ACTIVE_NOT_RECRUITING